# Semaglutide: About 12.7 kg More Weight Lost, More Dropouts

_Evidence Level: Moderate · Wajid R et al., Journal of diabetes and metabolic disorders, DOI 10.1007/s40200-026-02108-x_

*Efficacy and safety of semaglutide versus placebo in adults with overweight or obesity without diabetes: updated meta-analysis of randomized trials.*

- **Evidence Level**: Moderate
- **Why this grade**: Ten trials with 7,131 people chosen at random, but the authors rate the certainty of the evidence as low and results varied widely between trials.
- **Facts**: Design: Meta-analysis
- **Publication Types**: Journal Article, Review
- **Journal**: Journal of diabetes and metabolic disorders
- **Sample Size**: 7,131 adults in 10 trials
- **Authors**: Wajid R, Kumar R, Muneer M, Nauroz Ali M, Ul Mustafa J, Qamar J, Asif D, Ziaulhaque S, Sohail I, Khamisani FA, Noureen M, Fatima S, Saqlain A, Kumar L, Raja A
- **Graded and published**: 2026-10-31
- **Last edited**: 2026-11-04
- **Topics**: GLP-1, Metabolic Health
- **DOI**: https://doi.org/10.1007/s40200-026-02108-x
- **Free full text**: https://pmc.ncbi.nlm.nih.gov/articles/PMC13723587/
- **Original Source**: https://pubmed.ncbi.nlm.nih.gov/42968774/

## Summary

Adults with obesity or overweight but no diabetes lost about 12.7 kilograms more on semaglutide than on a dummy treatment. Semaglutide belongs to the GLP-1 drugs and is approved for long-term weight management. But the weight loss came with more side effects. And the size of the benefit varied a lot from one trial to the next.

A research team pooled ten trials with 7,131 adults in total. In each, participants were chosen at random to get semaglutide or a dummy treatment. People could join with a BMI of 30 or more. A BMI of 27 or more was enough if they also had an illness linked to their weight. Waist size shrank by about 9 centimeters more. Side effects were more common: 6 percent stopped treatment because of them, compared with 3 percent on the dummy.

Whether serious side effects became more common remained unclear. The data showed no clear difference, but could not rule out an important increase. The authors themselves rate the certainty of the results as low. The figures also only cover the treatment period in the trials, not what happened afterwards.

## Practical Takeaway

In trials, adults without diabetes lost about 12.7 kilograms more on semaglutide than on a dummy treatment.

---

_Canonical: https://longevity-cities.com/en/research/semaglutide-about-12-7-kg-more-weight-lost-more-dropouts · Part of Longevity Cities · Updated 2026-11-04_
